Susan is a market access executive with over 25 years of experience in pricing, health economics, and market access roles across both corporate and consulting environments. She has successfully led market access strategies for global launches in virology and oncology, with over $3 billion in revenues delivered in less than five years. Throughout her career, Susan has contributed to patient advocacy and policy recognition, playing a key role in corporate responsibility initiatives for major US healthcare reforms.
Susan holds a PhD in Managerial Science and Applied Economics from The Wharton School, an MSc in Public Policy and Administration from the London School of Economics, and a BA in Economics from Trinity University, Texas.
Leadership in global pricing and access strategies
Leadership in global pricing and access strategies
Expert in corporate benchmarking and pricing
Delivered significant growth by increasing sales volume by more than 20% for consulting clients.
Strategic advisor in virology and oncology
Led key initiatives in launching ground-breaking HIV therapies and corporate responsibility initiatives.
Experience in range of therapy areas:
Virology
Immunology
HIV
Oncology
Rare diseases and orphan drugs
Neurology and mental health disorders
FIECON exceeds my expectations by genuinely trying to achieve the best outcomes for our company. Their flexibility to adapt to unexpected changes and apply technical rigour, while respecting the commercial focus of the company is unparalleled. We see FIECON as part of our extended team.”
Senior Market Access Manager, Mid-sized Pharma
It was brilliantly smart and very well explained. It seems obvious now but that is what genius is, making complex things appear simple.”
Associate Director, Mid-sized Pharma
FIECON are my go to trusted partner. The team deliver high-quality work to timeline, every time. But more than this, FIECON has worked as part of our team, working towards achieving the best possible outcome by providing high level strategic input and challenge during our discussions.”
Market Access Director, Small Biotech
FIECON’s highly skilled expert team helped us to successfully tackle a number of tough pricing and access challenges. Apart from their flawless technical expertise, we have a reliable thought partner to pressure test new ideas and strategies that have a broader relevance than purely health economic aspects.”
Disease Area Director, Big Pharma
The pricing and market access research was a high quality work project, which included detailed information to define the overall and country strategy while the gap analysis was instrumental in the next steps preparation. ”
Executive Director, Biotech
FIECON’s strategic approach to problem solving is a breath of fresh air. We highly value their HTA knowledge and expertise, and they consistently deliver the best solution for us.”
Value Demonstration & Access Lead, Big Pharma
It is a pleasure to work with FIECON. The team are passionate about what they do and it really shows in their high-quality, creative solutions. Working with FIECON gives your projects the highest chance of success.”
Senior Vice President, Small Biotech
FIECON’s team is highly experienced, commercially focused, responsive and flexible. A particular strength I highlight is that FIECON’s team becomes a true partner with all company functions that they interact with. ”
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts. More info
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our marketing efforts.
